Note 6 - Capitalized Product Development Costs (Details Textual) - USD ($) $ in Thousands	3 Months Ended	9 Months Ended
Sep. 30, 2025	Sep. 30, 2024	Sep. 30, 2025	Sep. 30, 2024
Research and Development Asset Acquired in Transaction Other than Business Combination or Joint Venture Formation, Capitalized Cost	$ 570	$ 321	$ 1,516	$ 751
In Process Research and Development [Member]
Finite-Lived Intangible Asset, Useful Life (Year)	10 years		10 years

Amount of asset recognized from cost for research and development asset acquired in transaction other than business combination or from joint venture formation or both.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 350
-SubTopic 30
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482665/350-30-50-1

Name:	us-gaap_ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationFairValueAcquired
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration